Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ENVB

Enveric Biosciences Inc

May 22 • 04:00PM ET

2.21

-0.01 -0.45 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: DRUG GHRS CMPS ATAI BIVI

| Held by: PSIL VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-27.35	Insider Own	3.71%	Shs Outstand	3.68M	Perf Week	-1.78%
Market Cap	8.14M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	3.55M	Perf Month	-45.02%
Enterprise Value	3.23M	PEG	-	EPS next Q	-	Inst Own	9.43%	Short Float	24.97%	Perf Quarter	7.28%
Income	-11.58M	P/S	-	EPS this Y	-	Inst Trans	2.82%	Short Ratio	0.23	Perf Half Y	-62.16%
Sales	0.00M	P/B	0.82	EPS next Y	-	ROA	-154.76%	Short Interest	0.89M	Perf YTD	-39.12%
Book/sh	2.68	P/C	1.66	EPS next 5Y	-	ROE	-183.12%	52W High	17.64 -87.47%	Perf Year	-84.78%
Cash/sh	1.33	P/FCF	-	EPS past 3/5Y	75.07% 67.96%	ROIC	-162.44%	52W Low	1.71 29.24%	Perf 3Y	-99.59%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	10.63% 18.77%	Perf 5Y	-99.99%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	82.92%	Oper. Margin	-	ATR (14)	0.49	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	11.67	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	38.76	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	11.67	EPS Q/Q	92.58%	SMA20	-29.63%	Beta	1.17	Target Price	1800.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-16.27%	Rel Volume	0.03	Prev Close	2.22
Employees	6	LT Debt/Eq	0.00	Earnings	Mar 27 BMO	SMA200	-60.93%	Avg Volume	3.80M	Price	2.21
IPO	Aug 22, 1995	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	114,399	Change	-0.45%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)